
A Canadian company is developing a cannabis-centric solution for Cutaneous T-cell lymphoma (CTCL), an uncommon type of cancer occurring in adults aged 40 to 60 and sometimes in children.
READ MORE BELOW:
Source: http://bit.ly/2F65vue reposted by Cannabis News World . Original article by Anisha Dhiman
You must log in to post a comment.